Safety and Tolerability of BL-1020 in Hospitalized Subjects With Chronic Schizophrenia or Schizo-Affective Disorder

Clinical trial NCT00480571 · COMPLETED

Trial details

NCT number: NCT00480571
Sponsor: BioLineRx, Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Schizophrenia Schizoaffective Disorder

Start date: 2007-06-01
Primary completion: 2007-12-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.